References
- BakrisGLWeirMRAngiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?Arch Int Med20001606859310724055
- BjorholtIAnderssonFLKahanTThe cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE studyJ Int Med200225150817
- BurnsPGoughSBradburyAWManagement of peripheral arterial disease in primary careBMJ2003326584812637405
- ChoudhriAHClelandJGFRowlandsPCUnsuspected renal artery stenosis in peripheral vascular diseaseBMJ1990301119782261558
- Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
- HobbsSDThomasMEBradburyAWManipulation of the renin angiotensin system in peripheral arterial diseaseEur J Vasc Endovasc Surg2004285738215531190
- IglesiasJIHamburgerRJFeldmanLThe natural history of incidental renal artery stenosis in patients with aortoiliac vascular diseaseAm J Med2000109642711099684
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Eur J Vasc Endovasc Surg200733Suppl 1
- LamyAYusufSPogueJCost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) studyCirculation2003107960512600907
- LengGCFowkesFGRThe Edinburgh Claudication Questionnaire: an improved version of the WHO / Rose Questionnaire for use in epidemiological surveysJ Clin Epidemiol199245110191474406
- LeveyASBoschJPBreyerJA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med19991304617010075613
- MissourisCGBuckenhamTCappuccioFPRenal artery stenosis: A common and important problem in patients with peripheral vascular diseaseAm J Med19949610148304356
- National Kidney Foundation K/DOQI GuidelinesEvaluation of laboratory measurements for clinical assessment of kidney disease. Guideline 4. Estimation of GFR2007 [online] [Accessed 18 July 2007]. URL: http://www.kidney.org/professionals/doqi/kdoqi/p5_lab_g4.htm
- Peripheral Arterial Diseases Antiplatelet Consensus GroupAntiplatelet therapy in peripheral arterial disease. Consensus statementEur J Vasc Endovasc Surg20032611612819642
- PillayWRKanYMCrinnonJNfor the Joint Vascular Research GroupProspective multicentre study of the natural history of atherosclerotic renal artery disease in patients with peripheral vascular diseaseBr J Surg2002897374012027983
- SalmonPBrownMARenal artery stenosis and peripheral arterial disease: implications for ACE inhibitor therapyLancet19903363211974015
- SmithMGNevilleAMMiddletonJCClinical and economic benefits of ramipril: an Australian analysis of the HOPE studyInt Med J20033341419
- The Heart Outcomes Prevention Evaluation Study InvestigatorsThe HOPE (Heart Outcomes Prevention Evaluation) study: The design of a large, simple randomised trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular eventsCan J Cardiol199612127378605634
- The Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patientsN Engl J Med20003421455310639539